NCT04800614

A Study to Explore the Effect of Food Before a Single Dose of Sitravatinib

An Open-label, Randomized, Three-period, Crossover Study of the Effect of Food on the Pharmacokinetics of a Single Oral Dose of Sitravatinib in Healthy Adult Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 36 (actual)
• Sponsor: Mirati Therapeutics Inc. · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

An Open-label, Randomized, Three-period, Crossover Study of the Effect of Food on the Pharmacokinetics of a Single Oral Dose of Sitravatinib in Healthy Adult Subjects

Conditions

• Healthy Adults

Interventions

Type	Name	Description
DRUG	sitravatinib	100 mg sitravatinib on Day 1 of each of 3 periods

Timeline

• Start date: 2021-03-15
• Primary completion: 2021-07-06
• Completion: 2022-03-28
• First posted: 2021-03-16
• Last updated: 2022-04-06

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study